Must not be used in antibiotic-related diarrhoea. Insufficient data regarding chronic diarrhoea & this medicinal product. Immediately discontinue treatment if severe skin reactions appear. Risk of hypersensitivity, Quincke's/angioneurotic oedema, & angioedema of the face, extremities, lips & mucosa. Patients w/ history of angioedema not associated w/ racecadotril treatment may be at increased risk of angioedema. Cap: Not a substitute for rehydration, if required. Must not be used if signs of acute dysenteric syndrome are present eg, bloody stools or fever. Bioavailability may be reduced in patients w/ prolonged vomiting. Not recommended in patients w/ galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome. Caution in patients w/ renal or hepatic impairment. Preferable to avoid use during pregnancy. Should not be administered during breastfeeding. Must not be administered to infants & childn. Granules for oral susp: Does not modify usual rehydration regimens. Consider IV rehydration in case of serious or prolonged diarrhoea w/ significant vomiting or lack of appetite. Must not be administered in cases of prolonged or uncontrolled vomiting. Each 10-mg sachet contains 0.9665 g of sucrose & each 30-mg sachet contains 2.8995 g of sucrose; caution in patients w/ diabetes. Must not be administered to childn w/ renal or hepatic impairment. No clinical trials in infants <3 mth of age.